Sensei Biotherapeutics Announces Formation of New Immuno-Oncology Advisory Board
– Company brings together world-recognized leaders in immunobiology, cancer biology, and clinical and translational medicine –
GAITHERSBURG, Md.–(BUSINESS WIRE)–Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies, today announced the formation of a new Immuno-Oncology Advisory …